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Abstract
Background: The bone mineral density (BMD) o f the distal fem ur decreases by 16-36% w ith in  one year after total knee 
arthroplasty (TKA) because o f the femoral component's stress-shielding effect. The aim o f this prospective study was to 
determ ine the quantitative change from  the baseline BMD in the distal fem ur 1 year after patellofemoral arthroplasty 
using dual-energy X-ray absorptiometry (DXA).
Methods: Between December 2007 and December 2008, 14 patients had patellofemoral arthroplasty for isolated 
patellofemoral osteoarthritis. Distal femoral BMD was assessed using DXA in 2 regions o f interest (ROI) on the lateral 
view  2 weeks before and 12 m onths after patellofemoral arthroplasty. The contra-lateral knee was used as a control, 
w ith  BMD measurements performed in identical ROIs.
Results: The mean change from  baseline BMD in the operated knees after 1 year was -0.169 g /cm 2 (95% CI: -0.293 to  - 
0.046 g /cm 2) behind the anterior flange (-15%), and -0.076 g /cm 2 (95% CI: -0.177 to  0.024 g/cm 2) in the supracondylar 
area 1 cm above the prosthesis (-8%) (p = 0.01 and p = 0.13, respectively). The mean change from  baseline BMD in the 
non-operated knees after 1 year was 0.016 g /cm 2 (95% CI: -0.152 to  0.185 g /cm 2) behind the anterior flange (2%), and 
0.023 g /cm 2 (95% CI: -0.135 to 0.180 g /cm 2) in the supracondylar area 1 cm above the prosthesis (2%) (p = 0.83, and p =
0.76, respectively).
Conclusions: Our findings suggest tha t patellofemoral arthroplasty results in a statistically significant decrease in BMD 
behind the anterior flange.
Background
After total knee arthroplasty (TKA), the bone mineral 
density (BMD) of the distal femur decreases by 16-36% 
within one year because of the femoral component's 
stress-shielding effect [1-7]. Although the femoral com­
ponent in patellofemoral arthroplasty is smaller than in 
TKA, the mechanical loading, and consequently the 
stress distribution of the distal femoral bone, is altered 
compared with the physiological situation. This can lead 
to bone remodeling, resulting in decreased BMD behind 
the anterior flange of the femoral component. In TKA, 
bone loss in the distal anterior femur can lead to supra­
condylar fractures or loosening of the implant, and may 
induce difficulties during revision arthroplasty [8,9].
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Since patellofemoral arthroplasty is typically used in 
younger patients, conversion to TKA after painful femo- 
rotibial osteoarthritis develops will eventually be per­
formed in a relatively large proportion of patients [10]. 
Although the clinical outcome of TKA done later does 
not appear to be influenced by prior patellofemoral 
arthroplasty [11], the results of such a revision may, how­
ever, be compromised by loss of bone stock.
To date, no clinical studies have addressed the possible 
decrease in distal femoral BMD as a param eter of bone 
remodeling following patellofemoral arthroplasty. We 
hypothesized that because of the relative small size there 
is no significant stress-shielding effect behind the femoral 
component of a patellofemoral prosthesis resulting in a 
decrease in BMD in the distal femur. The prim ary objec­
tive was, therefore, to determine the change from base­
line in the BMD behind the anterior flange 1 year after
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patellofemoral arthroplasty using dual-energy X-ray 
absorptiometry (DXA).
Methods
In 2007, we initiated a prospective study to investigate the 
distal femoral BMD using DXA in patients undergoing 
patellofemoral arthroplasty. All patients who were 
planned for patellofemoral arthroplasty for isolated patel­
lofemoral osteoarthritis at Deventer Hospital, Deventer, 
The Netherlands, were evaluated for inclusion in the 
study. Patients with known rheumatic, renal, hepatic, or 
gastrointestinal disease, and patients using medication 
that interferes with mineral metabolism (i.e. treatm ent 
for osteoporosis or long-term  steroid therapy) were 
excluded from the study. Additionally, patients with a 
previous TKA or patellofemoral arthroplasty of the con­
tra-lateral knee were excluded. The study was approved 
by the Regional Ethics Committee (NL16145.075.07, 
December 2007) and Institutional Review Board.
Sample size was calculated using estimates of mean 
femoral BMD and standard deviation (SD) behind the 
anterior flange after TKA [1]. The reported mean BMD 
behind the anterior flange of a total knee prosthesis in the 
replaced knee was 0.94 g/cm2 (0.31), and 1.25 g/cm 2 
(0.30) in the contra-lateral, non-replaced knee [1]. A 
group sample size of 13 patients achieves 95% power to 
detect a difference of 0.31 g/cm2 between the null 
hypothesis that both group means are 1.25 g/cm 2, and the 
alternative hypothesis that the mean of group 2 (replaced 
knee) is 0.94 g/cm 2 with known group SDs of 0.31 g/cm 2 
and 0.30 g/cm 2 and with a significance level (alpha) of 
0.05 using a two-tailed paired t-test (PASS 2008, NCSS 
software, Kaysville, Utah).
Between December 2007 and December 2008, 2 ortho­
pedic surgeons who performed patellofemoral arthro­
plasty at Deventer Hospital recruited 14 patients. All 
patients provided w ritten informed consent. All eligible 
patients were preoperatively assessed by 1 of the 2 partic­
ipating orthopedic surgeons, who completed the Knee 
Society Knee Score (KSKS) and the Knee Society Func­
tional Score (KSFS). The Dutch version of the W estern 
Ontario and M cM aster Universities Osteoarthritis Index
3.1 (WOMAC) was completed by all patients. M easure­
m ent of the BMD in the distal femur was performed 
using DXA in the lateral view (GE Lunar Prodigy system, 
General Electrics, Oldelft Benelux B.V., Delft/ 
Veenendaal, The Netherlands) 2 weeks before patell­
ofemoral arthroplasty and 12 m onths after arthroplasty. 
M easurements of a calibration phantom  were performed 
each day before scanning the patients. All measurements 
were made by an independent radiographic technician. 
Both the scanning procedure and positioning of the 
patients and knees were standardized, with the patient in 
the lateral decubitus position and the knee flexed 15-30
degrees to obtain a true lateral scan. Two regions of inter­
est (ROI) were selected; one in the distal anterior area just 
behind the anterior flange of the prosthesis (centered 
between the tip of the fixation peg and the proximal end 
of the prosthesis) (ROI 1), and the other more proximally, 
in the supracondylar area 1 cm superior to the anterior 
flange of the femoral component (ROI 2) (Figure 1). ROI 
2 was selected as a reference ROI above the prosthesis, 
where stress-shielding was assumed to be negligible. The 
measured area of each ROI was 1 x 1 cm. The contra-lat­
eral, non-operated knee was used as a control, with BMD 
measurements in identical ROIs. We employed knee-spe­
cific software in all cases.
Two similarly experienced surgeons at our institution 
performed patellofemoral arthroplasty with the currently 
commercially available Richards type II prosthesis (Smith
& Nephew Inc., Memphis, Tennessee). Surgery was per­
formed under pneumatic tourniquet control and antibi-
Figure 1 Location of regions of interest (ROI) on a lateral radio­
graph of a right knee.
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otic prophylaxis using intravenous Cefazoline 1 g, 3 times 
daily, for the first 24 hours with the first dose adminis­
tered 30 minutes before application of the tourniquet. All 
operations were performed in an identical manner 
according to the manufacturers' instruction, as described 
elsewhere [10]. No intramedullary guiding rod was used 
during surgery. All 14 patients received the same postop­
erative treatm ent. We allowed patients protected weight 
bearing with crutches immediate after surgery, and full 
unrestricted weight bearing was allowed 6 weeks after 
surgery. All patients routinely received antithrombotic 
prophylaxis with a low-molecular-weight heparin (Frag­
min) for 6 weeks.
All patients had regular clinical follow-ups at 2 and 8 
weeks to evaluate wound healing and rehabilitation, DXA 
was not performed at these follow-up visits. At the 1-year 
follow-up, patients were clinically assessed using the 
KSKS and KSFS, and were asked to complete the 
W OMAC questionnaire. During follow-up, the radiologi­
cal examinations consisted of 2 radiographs (anteroposte­
rior standing and lateral non-weight bearing) performed
6 weeks and one year post surgery (Figure 2). Radiological 
findings were reported using the Knee Society total knee 
arthroplasty roentgenographic evaluation and scoring 
system [12].
All pertinent data were entered in a spreadsheet pro­
gram and analyzed using PASW Statistics 18 software 
(SPSS Inc, Chicago, Illinois). We performed descriptive 
analysis using the mean and standard deviation for con­
tinuous variables, and frequencies for categorical vari­
ables. The 95% confidence intervals (CI) were calculated 
for the absolute changes in BMD from baseline. The two­
tailed paired t-test was used to analyze for differences in 
preoperative and postoperative BMD. A linear regression 
model was used to evaluate for influence of BMI, age, and
sex on change in BMD from baseline. A p-value of less 
than 0.05 was considered significant in all the tests.
Results
Between December 2007 and December 2008, 14 patients 
had unilateral patellofemoral arthroplasty, receiving the 
Richards type II patellofemoral prosthesis. All 14 patients 
were available for the one year follow-up. The patient's 
demographic data are presented in Table 1.
Mean KSKS improved from 61 (range, 50 to 78) preop- 
eratively to 88 (range, 60 to 100) one year after surgery (p 
< 0.001). Mean KSFS improved from 65 (range, 50 to 80) 
preoperatively to 86 (range, 50 to 100) one year after sur­
gery (p = 0.004). The mean preoperative W OM AC scores 
improved from 50 (range, 22 to 69) to 23 (range, 4 to 39) 
one year after surgery (p < 0.001). No complications were 
noted from the surgical procedure within the study 
period. The 1-year radiographic follow-up showed that 
all prostheses were in good alignment without radiolu- 
cent lines or osteolysis.
Results of the BMD measurements are summarized in 
Table 2. In the operated knees, there was a 15% decrease 
in mean BMD at 12 months in ROI 1 (p = 0.01), and an 
8% decrease in ROI 2 (p = 0.13). In the non-operated 
knees, there was a 2% increase in the mean BMD at 12 
months in both ROI 1 and ROI 2 (p = 0.83 and p = 0.76, 
respectively).
Regression analysis of the change from baseline BMD 
for both regions of interest against BMI (regression coef­
ficient = 0.017, p = 0.3), age (regression coefficient =
0.002, p = 0.8), and sex (regression coefficient = -0.063, p 
= 0.6) demonstrated no significant relationships.
Discussion
The results of our prospective, 1-year DXA study dem on­
strate a statistically significant 15% decrease in BMD 
behind the anterior flange of the femoral component dur­
ing the first year after patellofemoral arthroplasty. To our 
knowledge, there has been no previous study that
Table 1: Patient characteristics.
Characteristic
Num ber o f knees 14
Side (right: left) 7 : 7
Mean (SD) age at surgery 53  (10) years
Sex (female: male) 9 : 5
Mean (SD) Height 175 (5 ) cm
Mean (SD) W eight 87  (13) kg
Mean (SD) body mass index 28  (4 ) kg/m 2
C ontinuous values are given as the mean w ith standard deviation 
in parentheses.
Figure 2 Lateral (left) and anteroposterior (right) radiographs of 
a right knee one year after patellofemoral arthroplasty.
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Table 2: Bone mineral density (BMD, g/cm2) measured in the distal femur before (t = 0) and 12 months after (t = 12) 
patellofemoral arthroplasty.









1.106 (0 .229) 
0.981 (0 .272)
1.099 (0 .266) 
0.930  (0 .175)
0.937  (0 .362) 
0.905  (0 .261)
1.115 (0 .315) 
0.952  (0 .266)
-0.169  (0 .204) 
-0.076  (0 .167)
0.016  (0 .251) 
0.023  (0 .234)
-0.293 to -0.046 
-0.177 to 0.024






Continuous values are given as the mean with standard deviation in parentheses. 
CI, confidence interval; ROI, region o f interest.
attem pted to use DXA measurements to evaluate changes 
in the distal femoral BMD after patellofemoral arthro­
plasty. Several investigators reported the results of BMD 
measurements after TKA and dem onstrated peripros- 
thetic bone loss of up to 36% adjacent to the implants [1­
7]. The general BMD as m easured in hip and spine, or the 
BMD in the contra-lateral knee, did not change after 
arthroplasty [1-3,7].
Finite-element models were used to determine whether 
patterns of bone resorption behind the femoral compo­
nent in TKA could be explained by strain-adaptive bone 
remodeling [13,14]. W ith a bonded femoral component, 
the predicted long-term bone loss would occur at the 
m ost distal part of the femur and behind the anterior part 
of the prosthesis [13]. These findings are in agreement 
with the results of clinical DXA studies, which observed 
loss of BMD behind the anterior flange of the femoral 
component in TKA [1-7]. Our results show that compa­
rable distal femoral bone loss occurs following patell- 
ofemoral arthroplasty. This suggests that the stress- 
shielding effect is similar to that which occurs after TKA, 
even with the smaller femoral component of the patell- 
ofemoral prosthesis (Figure 2). However, the clinical 
results do not seem to be compromised by the observed 
loss of bone. In a recent study, the long-term  outcomes of 
the Richards type II patellofemoral arthroplasty were 
reported [10]. The m ost common reasons for conversion 
in this series were progression of femorotibial osteoar­
thritis and revision for malpositioning that resulted in 
catching and instability. Loosening of the femoral compo­
nent was not observed, which is in accordance with the 
literature. Furthermore, the clinical outcome of later 
TKA does not appear to be influenced by prior patell- 
ofemoral arthroplasty [11,15]. No technical difficulties 
were experienced during conversion, and the condylar 
support in each knee was uncompromised.
The observed decrease in the BMD in the supracondy­
lar reference ROI 2 was not statistically significant. O ther 
investigators dem onstrated an 8% decrease in the BMD in 
this diaphyseal ROI at 1 year after total knee arthroplasty 
[5,7]. Soininvaara et al. suggested that this less pro­
nounced bone loss represented both operation-related 
and postoperative immobilization-induced bone loss, 
because age-related bone loss is m inor [5]. However, 
physical activity had improved in our patients, as dem on­
strated by the improvement in KSFS and W OM AC 
scores.
The current study has some limitations that should be 
noted. Follow-up examinations were performed at 1 year 
after surgery. W ith TKA, several investigators report that 
no additional remodeling occurs after 6-12 m onths [2,5­
7], while others stated that loss of BMD stabilizes within 2 
years [1,16]. Finite element models predict that bone 
resorption may continue after 2 years [13]. Thus, it is pos­
sible that a further decrease in BMD occurs in our 
patients. Another limitation is that we performed no pre­
cision measurements in our relatively small series. There­
fore, we assumed a precision similar to those reported by 
others using the same Lunar Prodigy system, albeit with 
possible software differences. The reported precision for 
BMD measurements on the lateral view of the anterior 
femur ranges from 1.3% to 3.6% [3,4,7,17,18]. Because of 
the relatively small size of the patellofemoral prosthesis, 
the ROI behind the anterior flange was also necessarily 
small, which may have resulted in weakened precision 
[17].
Although our study protocol excluded medical condi­
tions that could have affected the BMD, it is possible that 
other conditions may have existed that influenced the 
results. None of the patients had a severe medical disabil­
ity that limited the ability to walk, or had a disabling dis­
ease involving other joints of the lower extremities. We 
did not assess the am ount of physical activity at one-year
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follow-up and were therefore not able to evaluate for a 
relationship with change from baseline BMD.
Conclusions
Our findings suggest that Richards type II patellofemoral 
arthroplasty results in a statistically significant decrease 
in BMD behind the anterior flange. Newer designs, such 
as the Journey patellofemoral prosthesis (Smith & 
Nephew) and the Zimmer Gender Solutions PFJ system, 
employ a broader trochlear component. In theory, the 
geometry, size, and material properties may result in dif­
ferent patterns of stress shielding. Future studies should 
be aimed at evaluating BMD changes in these newer 
patellofemoral prostheses.
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